These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2156344)
1. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients]. Mohacsi P; Leonardi L; Waser M; Lüthy A; Laske A; Turina M; Gallino A Ther Umsch; 1990 Feb; 47(2):157-63. PubMed ID: 2156344 [TBL] [Abstract][Full Text] [Related]
2. [Prevention of cytomegalovirus infection following heart transplantation]. Laske A; Carrel T; Niederhäuser U; Bauer E; Pasic M; von Segesser LK; Gallino A; Turina M Helv Chir Acta; 1992 Jan; 58(4):527-32. PubMed ID: 1316336 [TBL] [Abstract][Full Text] [Related]
3. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients]. Eichler C; Kaden J; May G Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294 [TBL] [Abstract][Full Text] [Related]
4. [Importance of screening for antibodies to cytomegalovirus in organ transplantation]. Milbradt H; Flik J; Stangel W; Heigel R Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866 [TBL] [Abstract][Full Text] [Related]
5. Three-year experience with human cytomegalovirus infections in heart transplant recipients. Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498 [TBL] [Abstract][Full Text] [Related]
7. [The significance of cytomegalovirus infection in the period after a heart transplant]. Manito N; Pérez JL; Roca J; Niubó J; Gausí C; Castells E Rev Esp Cardiol; 1995; 48 Suppl 7():108-14. PubMed ID: 8775825 [TBL] [Abstract][Full Text] [Related]
8. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269 [TBL] [Abstract][Full Text] [Related]
9. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864 [TBL] [Abstract][Full Text] [Related]
12. [Cytomegalovirus diseases following allogenic kidney transplantation]. Tenschert W; Huland H Med Klin (Munich); 1992 Oct; 87 Suppl 1():43-8. PubMed ID: 1334221 [TBL] [Abstract][Full Text] [Related]
13. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation. Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893 [TBL] [Abstract][Full Text] [Related]
14. The spectrum of cytomegalovirus infection following human heart-lung transplantation. Burke CM; Glanville AR; Macoviak JA; O'Connell BM; Tazelaar HD; Baldwin JC; Jamieson SW; Theodore J J Heart Transplant; 1986; 5(4):267-72. PubMed ID: 3040942 [TBL] [Abstract][Full Text] [Related]
15. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status? Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514 [TBL] [Abstract][Full Text] [Related]
17. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation. Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172 [TBL] [Abstract][Full Text] [Related]
18. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients]. Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666 [TBL] [Abstract][Full Text] [Related]